Skip to main content

Table 2 Comparison of the liver stiffness (LSM) between before and after treatment within each liver stiffness category

From: Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Liver stiffness

Before treatment

After treatment

Decline %

p-value

Total population

8.80 (5.80, 21.00)

5.80 (4.40, 12.60)

34.09%

0.002*

 < 10 kPa

6.00 (3.6, 9.5)

4.57 (2.0, 9.8)

23.83%

0.0001*

10–15 kPa

12.60 (10.5, 14.8)

11.90 (10.1, 14.0)

8.40%

0.042*

 > 15 kPa

28.30 (15.9, 67.8)

24.25 (15.4, 39.7)

14.31%

0.0001*

  1. Data are expressed as median (interquartile range). p-value: probability value. *Significant (p < 0.05)